Date: April 8, 2008
Creator: Jason, Leonard A.; Benton, Mary C.; Valentine, Lisa M.; Johnson, Abra & Torres-Harding, Susan
Description: This article discusses the economic impact of ME/CFS: Individual and societal costs. Background: ME/CFS is characterized by debilitating fatigue in addition to other physical and cognitive symptoms. It is estimated to affect over 800,000 adults in the U.S. ME/CFS often results in diminished functionality and increased economic impact. The economic impact of an illness is generally divided into two categories: direct and indirect costs. Despite high prevalence rates and the disabling nature of the illness, few studies have examined the costs of ME/CFS at the individual and societal level. In fact, of the four studies examining the economic impact of ME/ME/CFS only two used a U.S. sample. The current study used community and tertiary samples to examine the direct costs of ME/CFS. Methods: Using archival data, Study 1 examined the direct cost of ME/CFS in a community-based sample in Chicago. Study 2 estimated the direct cost of ME/CFS in a tertiary sample in Chicago. Both Study 1 and Study 2 assessed direct costs using office visit costs, medical test costs, and medication costs. Results: For Study 1, the annual direct total cost per ME/CFS patient was estimated to be $2,342, with the total annual direct cost of ME/CFS to society ...
Contributing Partner: UNT College of Arts and Sciences